Reader-exclusive · 10% off DoNotAge Nitralis Review: Trial, Formula & Benefits on DoNotAge CODE BB10

DoNotAge Nitralis supplement, white jar of 366 capsules with black DNA emblem

DoNotAge · Nitralis · Our featured branded nitric oxide booster · 2026

DoNotAge Nitralis Review — The Three-Ingredient Formula With Its Own Human Trial

Name: Editorial review of DoNotAge Nitralis Review: Trial, Formula & Benefits
Rating: 4.8
Author: Dr. Khaled Mahmoud, MBBCh

FEATURED BRANDED NO BOOSTER Product Review12 min readLast verified 27 Sep 2026

4.8/5Editorial product score for finished-formula human research, coherent three-ingredient rationale, capsule usability and research traceability—not a clinical efficacy percentage.

What stands out

Published randomized, placebo-controlled human research tested the actual Nitralis formula in 85 adults.
Fermented beet, magnesium ascorbate and epimedium offer three complementary nitric-oxide research directions.
Clear current label: two convenient 400 mg capsules per day (800 mg total).

Things to know first

Clinical-outcome trials and independent confirmation of exact study-to-retail formulation equivalence are still needed.

Key takeaways

Nitralis has something unusual for a branded nitric oxide formula: its own published 85-person randomized placebo-controlled human pilot.
After 30 days, 60.5% of Nitralis users reached the prespecified salivary-strip response threshold versus 11.9% on placebo; this is a biomarker result.
The formula combines fermented beet's dietary nitrate concept, ascorbate-related nitrite chemistry and epimedium's experimental NO-signaling research.
Current retail serving is 800 mg daily (two 400 mg capsules); the pilot describes 400 mg daily, so precise dose and formulation equivalence await confirmation.
We feature Nitralis for its finished-formula trial and coherent design while retaining clear safety and clinical-outcome boundaries. Affiliate code BB10 may provide 10% off.

Bottom line

Our featured branded nitric oxide support formula: a thoughtful three-ingredient combination with its own positive 85-person placebo-controlled salivary biomarker pilot, not just ingredient-only citations. The 4.8/5 editorial product rating reflects the finished-formula research, formulation rationale and usability, while direct clinical efficacy, proved synergy and precise current-batch equivalence remain unestablished.

Our verdict

DoNotAge Nitralis is Biohack Blueprint's featured branded nitric oxide support formula for 2026. The defining advantage is product-specific published randomized human research: 60.5% of the active group met a prespecified salivary-strip response threshold after 30 days versus 11.9% of placebo. Its three-ingredient design combines a fermented-beet nitrate-pathway concept, ascorbate-associated nitrite chemistry and epimedium's experimental signaling research. We rate the product 4.8/5 for this research-backed formulation concept and research traceability, without implying independently demonstrated ingredient synergy, superiority over every competing product or proven blood-pressure or exercise benefits.

Published 85-person randomized finished-formula pilot; current-batch certificate and exact study-to-retail equivalence remain to be verified

Reader-exclusive

DoNotAge Nitralis Review: Trial, Formula & Benefits — via DoNotAge

Use code 10% off

14-day money-back guarantee
Varies by pack and daily dose supply per bottle
Subscribe & save available
Fast shipping from DoNotAge

Get 10% off on DoNotAge with BB10 →

DoNotAge handles pricing, fulfilment, and customer support for this product. Biohack Blueprint may earn a commission from purchases made through links on this page, at no extra cost to you. This does not affect our evidence grading or editorial verdict.

Published randomized finished-formula pilot 85 adults · 30-day placebo control Three complementary ingredient rationales Product-specific human data

Key facts & composition

Product	Nitralis® proprietary nitric-oxide support blend Fermented beet, magnesium ascorbate and epimedium in published study
Current labelled serving	2 × 400 mg capsules = 800 mg/day Manufacturer's current product information; verify label if formulation changes
Product-specific human trial	85 adults; randomized 30-day pilot 43 Nitralis and 42 placebo participants; salivary test-strip endpoint
Published trial intervention	400 mg/day as reported Current retail 800 mg/day regimen differs; exact formulation equivalence unverified
Our key reason to feature Nitralis	Published randomized study of the finished blend 85 adults over 30 days; salivary test-strip endpoint

Composition

Ingredient	Amount	Form	Source
Fermented beet	Part of 800 mg proprietary blend; separate amount undisclosed	Fermented beet constituent	Published Nitralis pilot formula
Dietary beet may supply nitrate, but the exact nitrate content of the retail Nitralis serving is not established by the paper. Beetroot-juice RCT results should not be treated as direct product outcomes.
Magnesium ascorbate	Part of 800 mg proprietary blend; separate amount undisclosed	Magnesium and vitamin C salt	Published Nitralis pilot formula
The current label's independently verified elemental magnesium and vitamin C amounts were not available for this review. Avoid attributing specific clinical effects without dose disclosure.
Epimedium	Part of 800 mg proprietary blend; separate amount undisclosed	Botanical constituent	Published Nitralis pilot formula
Individual epimedium extract dose and icariin standardization were not established in the accessible clinical paper. Drug-interaction assessment may require the current detailed ingredient label.

How it works

The Nitralis trio has a coherent scientific rationale. Fermented beet is the potential nitrate source in the enterosalivary nitrate–nitrite pathway. Ascorbate participates in the conversion of nitrite to nitric oxide under acidic gastric conditions in laboratory and human-juice studies. Epimedium constituents have experimental vascular and PDE5-related signaling research. The 85-person product trial evaluated the blend as a whole; it did not isolate each ingredient's contribution or prove synergy.

1

Fermented beet: enterosalivary nitrate–nitrite pathway

Beet-derived dietary nitrate can circulate into saliva, where nitrate-reducing oral bacteria convert it into nitrite. Nitrite can then contribute to nitric-oxide generation under favorable conditions. Fermented beet provides the central nitrate-pathway design rationale for Nitralis, though the current product's independently verified nitrate amount is not established by the trial.

2

Magnesium ascorbate: complementary nitrite chemistry

Ascorbate (vitamin C) has been shown to help convert swallowed nitrite into nitric oxide in acidic human gastric juice (Iijima et al., PMID 12737438). This gives the combination of beet-derived nitrate and an ascorbate source a coherent biochemical rationale. The published Nitralis pilot tested the full blend but did not isolate the contribution of this component or prove ingredient synergy.

3

Epimedium: experimental endothelial NO-signaling pathway

Epimedium contains compounds investigated in preclinical vascular research. In one cell study, isolated icariin activated endothelial nitric oxide synthase-related signaling in human umbilical vein endothelial cells (Koizumi et al., PMID 20416296). Clinical effects of the epimedium constituent within the current proprietary Nitralis blend have not been independently isolated.

This review draws on 14 peer-reviewed papers indexed in our Nitric Oxide Data Center →

The evidence

The key product-specific result is a published 85-person, 30-day randomized placebo-controlled pilot showing a greater salivary test-strip response with Nitralis than placebo. This is meaningful early research for the named blend. The grade below refers only to the measured biomarker claim; studies of dietary nitrate or isolated amino acids provide additional scientific context but are not finished-Nitralis efficacy trials. Blood-pressure, functional vascular, exercise and sexual-health outcomes still require direct testing.

C

30-day salivary test-strip response in the finished-formula human pilot

Tier 3

The published manufacturer-funded, randomized placebo-controlled 85-person pilot directly studied Nitralis and reported a +90 median day-30 strip-unit change versus zero with placebo. Responders accounted for 26/43 (60.5%) in the Nitralis group and 5/42 (11.9%) on placebo. A promising product-specific surrogate-biomarker result; salivary strips do not directly quantify circulating nitric oxide or prove clinical functional benefit.

Paige Baily 2025, Abrar M Babateen et al. 2019, Ashwin Modi et al. 2017

Clinical pharmacology

Current manufacturer labeling specifies a convenient two-capsule serving: 400 mg per capsule, or 800 mg per day. The 2025 pilot describes 400 mg daily. Ingredient-by-ingredient amounts, a standardized nitrate assay and exact study-to-retail batch equivalence were not independently established in the reviewed sources. Use the current product instructions, rather than extrapolating a dose-response relationship from the pilot.

Dose tiers

Tier	Dose	Frequency	Duration	Notes
Published clinical study	400 mg daily	Daily	30 days	The manufacturer-funded pilot studied a daily 400 mg intervention and semi-quantitative salivary outcomes. Do not assume trial findings increase proportionally with dose.
Current retail label	800 mg daily (two 400 mg capsules)	Once daily, per label	As directed by current manufacturer label	Current manufacturer recommendation verified in September 2026. The published trial reports 400 mg/day, and batch-to-trial equivalence is not independently established.

From bench to bedside

Pathway	Preclinical finding	Human translation	Confidence
Beet nitrate and ascorbate: complementary conversion pathways	Dietary nitrate may enter the oral nitrate–nitrite pathway; ascorbate can facilitate nitrite-to-NO chemistry at acidic gastric pH.	Independent human gastric-juice research supports the chemical step. Nitralis's full-blend pilot found increased salivary strip readings, but did not isolate ingredient effects or directly measure vascular endpoints.	Established pathway chemistry; unproven formula synergy
Epimedium constituents and experimental endothelial signaling	Icariin derived from epimedium stimulated eNOS-linked signaling in human endothelial cells in vitro (Koizumi 2010; PMID 20416296).	Plausible complementary formula component; its individual dose, contribution and clinical benefit in the proprietary Nitralis blend were not established in the pilot.	Laboratory evidence; formulation-specific clinical contribution unconfirmed

Drug interactions

Clinician review advised

Blood-pressure medicines and symptomatic hypotension

NO-related dietary components may add to blood-pressure-lowering effects; the magnitude of any interaction with this proprietary formula is unstudied.

Recommendation:

Discuss use with your prescriber if you take antihypertensives, experience faintness, have low blood pressure or significant cardiovascular disease. Do not adjust prescribed medication on the basis of saliva-strip readings.

Prescription combination contraindicated; supplement assessment needed

Prescription organic nitrates and PDE5 inhibitors

Organic nitrate medications and PDE5 inhibitors such as sildenafil can produce dangerous hypotension together. Dietary nitrate is not identical to prescription organic nitrate therapy.

Recommendation:

Never combine prescription organic nitrate medication with a PDE5 inhibitor unless specifically directed in an appropriate specialist context. If taking either medicine, ask your clinician to assess Nitralis ingredients and blood-pressure risk; direct Nitralis interaction trials are unavailable.

Bioavailability tips

Because oral bacteria help reduce dietary nitrate to nitrite, antiseptic mouthwash can alter this pathway. Do not stop prescribed dental therapy on this basis. Neither saliva-strip changes nor theoretical absorption effects identify the optimal individual dose of Nitralis, and no reliable dose-response trial of the current retail formula is available.

Therapeutic positioning

Nitralis is our featured branded nitric oxide booster because the manufacturer has published a randomized, placebo-controlled human trial of the finished formula. We also value the coherent concept behind fermented beet, magnesium ascorbate and epimedium—three complementary research directions in one capsule. The trial measured a salivary test-strip outcome; clinical-endpoint confirmation and retail-batch equivalence remain future steps.

Standardized nitrate-rich beetroot juice

Dietary nitrate More direct clinical-outcome trials for beetroot; only Nitralis pilot measures the branded blend

Beetroot juice has more randomized human studies with measured blood-pressure and exercise endpoints. Nitralis adds a proprietary multi-ingredient formulation and one product-specific pilot, but its nitrate content and equivalent clinical efficacy remain unconfirmed.

Pure L-citrulline

Amino-acid precursor Different mechanisms and studied outcomes

Citrulline increases circulating arginine in human pharmacokinetic studies; its clinical effects depend on population and protocol. Nitralis targets different pathways, so neither ingredient's clinical findings can be generalized to the other.

Pure L-arginine

Nitric-oxide synthase substrate Different evidence bases; medication and cardiac history matter

L-arginine has a larger and mixed human research base, including hypertension, erectile function and important post-infarction safety data. Nitralis has only preliminary product-specific salivary biomarker evidence to date.

Regular physical activity, a vegetable-rich diet, sleep and evidence-based cardiovascular care have wider direct human clinical evidence than a nitric-oxide supplement. Nitralis is an optional product, not a substitute for treating hypertension or vascular disease.

This product review is educational and is not a prescription. Nitralis is not a substitute for antihypertensives, approved erectile-dysfunction treatment, cardiology evaluation, a balanced diet or exercise. Seek urgent care for sudden chest pain, shortness of breath or limb ischemia symptoms.

About buying through us

Is the claimed 226% increase a proven increase in circulating nitric oxide?

No. The trial's +226% figure describes an arithmetic mean percentage change in semi-quantitative salivary test-strip readings, while the median percentage change was +64%. These are not direct measurements of circulating nitric oxide and do not demonstrate an equivalent clinical benefit.

Does Nitralis have a certificate of analysis?

The manufacturer describes batch testing. A current batch-specific certificate verifying the current product's formula and standardized nitrate content was not independently confirmed for this review. Ask DoNotAge for the exact batch documentation before making a quality-based decision.

Will Nitralis lower my blood pressure?

That has not been established in direct Nitralis trials. Research on standardized beetroot juice and other dietary-nitrate products is more extensive, but individual effects vary, and some studies in treated hypertension are neutral. Do not replace prescribed blood-pressure treatment.

Reader questions

Has Nitralis been tested in humans?

Yes. Its published 2025 randomized, placebo-controlled pilot involved 85 adults over 30 days. It reported improved salivary test-strip readings; the study did not measure cardiovascular events, blood pressure, endothelial function, erectile-function scores or performance.

What is the recommended Nitralis dose?

The current DoNotAge label recommends two 400 mg capsules per day (800 mg total). The published pilot reports 400 mg daily. Follow the current manufacturer's instructions, and note that dose and formulation equivalence have not been independently established.

Will Nitralis lower my blood pressure?

That has not been established in direct Nitralis trials. Research on standardized beetroot juice and other dietary-nitrate products is more extensive, but individual effects vary, and some studies in treated hypertension are neutral. Do not replace prescribed blood-pressure treatment.

Can I use Nitralis with sildenafil or prescription nitrate medication?

Ask your prescriber to assess the complete formula and your cardiovascular history. Prescription organic nitrates must not be combined with PDE5 inhibitors because of serious hypotension risk; a dietary supplement is not chemically identical to prescribed nitrates, but Nitralis-specific interactions have not been studied.

Does Nitralis have a certificate of analysis?

The manufacturer describes batch testing. A current batch-specific certificate verifying the current product's formula and standardized nitrate content was not independently confirmed for this review. Ask DoNotAge for the exact batch documentation before making a quality-based decision.

Is the claimed 226% increase a proven increase in circulating nitric oxide?

No. The trial's +226% figure describes an arithmetic mean percentage change in semi-quantitative salivary test-strip readings, while the median percentage change was +64%. These are not direct measurements of circulating nitric oxide and do not demonstrate an equivalent clinical benefit.

Is there a Nitralis discount code?

Use Biohack Blueprint's affiliate code BB10 for an eligible 10% discount at DoNotAge. Offers and exclusions can change; we may earn a commission from eligible orders using our affiliate link.

Editorial credibility

Portrait of Dr. Khaled Mahmoud, ICU physician and founder of Biohack Blueprint

Author

Dr. Khaled Mahmoud, MBBCh

MBBCh

Critical Care Medicine, Longevity Science & Editorial Direction

Editorial product score for finished-formula human research, coherent three-ingredient rationale, capsule usability and research traceability—not a clinical efficacy percentage.

Ready to try DoNotAge Nitralis Review: Trial, Formula & Benefits?

Use code BB10 for 10% off on DoNotAge.

Shop DoNotAge Nitralis Review: Trial, Formula & Benefits on DoNotAge →

14-day money-back guarantee